CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 164 filers reported holding CARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $980 | -40.6% | 583,460 | 0.0% | 0.01% | -38.1% |
| Q2 2023 | $1,651 | -42.4% | 583,460 | 0.0% | 0.02% | -46.2% |
| Q1 2023 | $2,865 | -54.3% | 583,460 | 0.0% | 0.04% | -53.0% |
| Q4 2022 | $6,266 | -99.9% | 583,460 | 0.0% | 0.08% | +10.7% |
| Q3 2022 | $5,461,000 | +2.5% | 583,460 | 0.0% | 0.08% | +11.9% |
| Q2 2022 | $5,327,000 | -24.9% | 583,460 | 0.0% | 0.07% | -13.0% |
| Q1 2022 | $7,089,000 | -0.3% | 583,460 | 0.0% | 0.08% | +14.9% |
| Q4 2021 | $7,107,000 | -21.2% | 583,460 | 0.0% | 0.07% | -28.0% |
| Q3 2021 | $9,014,000 | +8.3% | 583,460 | 0.0% | 0.09% | +8.1% |
| Q2 2021 | $8,326,000 | -45.5% | 583,460 | -17.1% | 0.09% | -42.7% |
| Q1 2021 | $15,272,000 | +43.5% | 703,460 | 0.0% | 0.15% | +40.2% |
| Q4 2020 | $10,643,000 | +18.9% | 703,460 | 0.0% | 0.11% | +5.9% |
| Q3 2020 | $8,952,000 | -25.6% | 703,460 | 0.0% | 0.10% | -27.9% |
| Q2 2020 | $12,029,000 | +29.4% | 703,460 | 0.0% | 0.14% | +7.7% |
| Q1 2020 | $9,293,000 | -18.0% | 703,460 | 0.0% | 0.13% | -3.7% |
| Q4 2019 | $11,333,000 | -11.9% | 703,460 | 0.0% | 0.14% | -17.2% |
| Q3 2019 | $12,859,000 | -15.0% | 703,460 | 0.0% | 0.16% | -13.3% |
| Q2 2019 | $15,124,000 | +437.3% | 703,460 | +390.4% | 0.19% | +422.2% |
| Q1 2019 | $2,815,000 | +41.3% | 143,460 | -6.4% | 0.04% | +24.1% |
| Q4 2018 | $1,992,000 | -66.4% | 153,210 | -38.1% | 0.03% | -61.8% |
| Q3 2018 | $5,926,000 | +6.7% | 247,429 | -14.7% | 0.08% | -1.3% |
| Q2 2018 | $5,553,000 | +93.6% | 289,950 | +25.1% | 0.08% | +75.0% |
| Q1 2018 | $2,869,000 | -12.3% | 231,775 | -13.3% | 0.04% | -6.4% |
| Q4 2017 | $3,273,000 | -17.9% | 267,416 | -8.2% | 0.05% | -17.5% |
| Q3 2017 | $3,988,000 | +57.0% | 291,341 | +76.6% | 0.06% | +46.2% |
| Q2 2017 | $2,540,000 | -35.6% | 165,011 | -23.1% | 0.04% | -41.8% |
| Q1 2017 | $3,946,000 | +32.8% | 214,584 | -32.9% | 0.07% | +17.5% |
| Q4 2016 | $2,971,000 | +32.8% | 319,820 | +19.3% | 0.06% | +46.2% |
| Q3 2016 | $2,238,000 | +73.6% | 268,000 | 0.0% | 0.04% | +56.0% |
| Q2 2016 | $1,289,000 | -20.9% | 268,000 | +2.3% | 0.02% | -21.9% |
| Q1 2016 | $1,630,000 | -63.1% | 262,000 | 0.0% | 0.03% | -58.4% |
| Q4 2015 | $4,417,000 | -8.6% | 262,000 | -22.5% | 0.08% | -4.9% |
| Q3 2015 | $4,831,000 | -30.7% | 338,081 | -41.1% | 0.08% | +62.0% |
| Q2 2015 | $6,970,000 | +148.8% | 573,682 | +105.7% | 0.05% | +25.0% |
| Q1 2015 | $2,802,000 | +32.7% | 278,841 | +31.6% | 0.04% | +29.0% |
| Q4 2014 | $2,112,000 | +26.2% | 211,841 | +5.2% | 0.03% | +24.0% |
| Q3 2014 | $1,674,000 | – | 201,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |